This company has been acquired
Sharps Compliance Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Belangrijke informatie
77.0%
Groei van de winst
76.4%
Groei van de winst per aandeel
Healthcare Groei van de industrie | 8.5% |
Inkomstengroei | 16.1% |
Rendement op eigen vermogen | 6.3% |
Nettomarge | 5.8% |
Laatste winstupdate | 31 Mar 2022 |
Recente prestatie-updates uit het verleden
Recent updates
Aurora Capital Partners affiliate to acquire Sharps Compliance for $8.75 per share
Jul 12We Like These Underlying Return On Capital Trends At Sharps Compliance (NASDAQ:SMED)
Jul 02Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Jun 13Sharps Compliance Corp.'s (NASDAQ:SMED) Shareholders Might Be Looking For Exit
May 25Here's Why I Think Sharps Compliance (NASDAQ:SMED) Might Deserve Your Attention Today
May 03Sharps Compliance: Update Prior To Important Earnings
Apr 26Sharps Compliance: An Operator In The Medical Waste Industry
Jan 04Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Dec 06Time To Worry? Analysts Just Downgraded Their Sharps Compliance Corp. (NASDAQ:SMED) Outlook
Aug 20These 4 Measures Indicate That Sharps Compliance (NASDAQ:SMED) Is Using Debt Reasonably Well
Jun 18Sharps Compliance: Undervalued, Even If Growth Returns To Historical Levels
Jun 04With EPS Growth And More, Sharps Compliance (NASDAQ:SMED) Is Interesting
May 20Are Investors Undervaluing Sharps Compliance Corp. (NASDAQ:SMED) By 39%?
May 07Sharps Compliance EPS beats by $0.27, beats on revenue
Apr 28What Type Of Shareholders Own The Most Number of Sharps Compliance Corp. (NASDAQ:SMED) Shares?
Mar 15Has Sharps Compliance (NASDAQ:SMED) Got What It Takes To Become A Multi-Bagger?
Mar 01Upgrade: Analysts Just Made A Substantial Increase To Their Sharps Compliance Corp. (NASDAQ:SMED) Forecasts
Feb 02Earnings Beat: Sharps Compliance Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 01Is Sharps Compliance (NASDAQ:SMED) Weighed On By Its Debt Load?
Jan 26Sharps Compliance reports robust order activity
Jan 11Is There An Opportunity With Sharps Compliance Corp.'s (NASDAQ:SMED) 33% Undervaluation?
Jan 05Don't Ignore The Fact That This Insider Just Sold Some Shares In Sharps Compliance Corp. (NASDAQ:SMED)
Dec 18Shareholders Are Thrilled That The Sharps Compliance (NASDAQ:SMED) Share Price Increased 117%
Dec 07Is Sharps Compliance Corp. (NASDAQ:SMED) Popular Amongst Insiders?
Nov 18Does Sharps Compliance (NASDAQ:SMED) Have A Healthy Balance Sheet?
Jul 24Does The Market Have A Low Tolerance For Sharps Compliance Corp.'s (NASDAQ:SMED) Mixed Fundamentals?
Jul 06Opbrengsten en kosten
Hoe Sharps Compliance geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
31 Mar 22 | 69 | 4 | 17 | 0 |
31 Dec 21 | 79 | 11 | 17 | 0 |
30 Sep 21 | 77 | 12 | 16 | 0 |
30 Jun 21 | 76 | 13 | 16 | 0 |
31 Mar 21 | 70 | 10 | 15 | 0 |
31 Dec 20 | 53 | 2 | 14 | 0 |
30 Sep 20 | 51 | 1 | 14 | 0 |
30 Jun 20 | 51 | 2 | 14 | 0 |
31 Mar 20 | 51 | 1 | 14 | 0 |
31 Dec 19 | 50 | 1 | 13 | 0 |
30 Sep 19 | 48 | 1 | 12 | 0 |
30 Jun 19 | 44 | 0 | 12 | 0 |
31 Mar 19 | 42 | 0 | 12 | 0 |
31 Dec 18 | 42 | 0 | 12 | 0 |
30 Sep 18 | 41 | -1 | 11 | 0 |
30 Jun 18 | 40 | -1 | 11 | 0 |
31 Mar 18 | 41 | 0 | 11 | 0 |
31 Dec 17 | 40 | 0 | 11 | 0 |
30 Sep 17 | 38 | 0 | 11 | 0 |
30 Jun 17 | 38 | -1 | 12 | 0 |
31 Mar 17 | 37 | -2 | 12 | 0 |
31 Dec 16 | 35 | -2 | 11 | 0 |
30 Sep 16 | 35 | -1 | 11 | 0 |
30 Jun 16 | 33 | 0 | 11 | 0 |
31 Mar 16 | 34 | 1 | 10 | 0 |
31 Dec 15 | 33 | 1 | 10 | 0 |
30 Sep 15 | 32 | 1 | 10 | 0 |
Kwaliteitswinsten: SMED has a large one-off gain of $2.2M impacting its March 31 2022 financial results.
Groeiende winstmarge: SMED's current net profit margins (5.8%) are lower than last year (14.2%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: SMED has become profitable over the past 5 years, growing earnings by 77% per year.
Versnelling van de groei: SMED's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: SMED had negative earnings growth (-59.4%) over the past year, making it difficult to compare to the Healthcare industry average (6.1%).
Rendement op eigen vermogen
Hoge ROE: SMED's Return on Equity (6.3%) is considered low.